Updated COVID booster tied to strong Omicron immune response | CIDRAP
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Updated Bivalent Boosters Offer Extra Protection Against COVID-19
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
Why and When to Get a Bivalent Covid-19 Booster | Johns Hopkins | Bloomberg School of Public Health
COVID-19 Bivalent Boosters | Johns Hopkins | Bloomberg School of Public Health
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
Studies show real-world usefulness of bivalent COVID boosters | CIDRAP
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
New Omicron-specific vaccines offer similar protection to existing boosters
Evidence to recommendation Framework: Bivalent COVID-19 vaccine booster doses
NEJM on X: "Figure 1. Effectiveness of Bivalent Boosters According to the Interval since Administration. https://t.co/hIVtIujZoq #Covid19 https://t.co/KBljA6y7NR" / X
Updated COVID boosters give significant protection, data show - Los Angeles Times
COVID-19 BIVALENT BOOSTER EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION - CROI Conference
FDA clears the way for additional bivalent boosters for certain vulnerable individuals | CNN
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
